Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · IEX Real-Time Price · USD

40.14

+2.60 (6.93%)

At close: Apr 23, 2024, 4:00 PM

38.14

-2.00 (-4.98%)

After-hours: Apr 23, 2024, 6:07 PM EDT

Soleno Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-38.99	-24.07	-30.91	-24.64	-30.77	-13.34	-15.39	-15.72	-15.91	-13.24	Upgrade
Depreciation & Amortization	2.28	2.25	2.25	2.24	2.34	1.96	1.61	0.02	0.11	0.03	Upgrade
Share-Based Compensation	5.95	2.53	3.28	1.5	0.83	1.26	1.16	0.76	0.94	0.35	Upgrade
Other Operating Activities	5.82	-1.5	-2.39	-4.32	10.23	-1.57	2.67	-2.22	4.56	8.38	Upgrade
Operating Cash Flow	-24.94	-20.78	-27.77	-25.22	-17.38	-11.68	-9.95	-13.5	-10.3	-4.48	Upgrade
Capital Expenditures	0	-0.01	-0.02	-0.01	-0.02	-0.01	-0	-0.01	-0.06	-0.03	Upgrade
Acquisitions	0	0	0	0	0.5	0	-0.57	0	-1.25	0	Upgrade
Other Investing Activities	-	-	-	-	0.05	-0.17	0.73	-0.02	-0.02	-	Upgrade
Investing Cash Flow	0	-0.01	-0.02	-0.01	0.53	-0.18	0.15	-0.04	-1.32	-0.03	Upgrade
Share Issuance / Repurchase	180.02	14.11	0	53.74	14.48	16.3	23.95	0.07	1.73	10.73	Upgrade
Debt Issued / Paid	0	0	-0.01	-0.02	-0	0	0	0	-0.1	2.59	Upgrade
Other Financing Activities	-	-0.02	-0.12	-	-	1.53	0.23	10.7	7.53	-2.12	Upgrade
Financing Cash Flow	180.02	14.09	-0.13	53.72	14.48	17.83	24.17	10.77	9.16	11.2	Upgrade
Net Cash Flow	155.08	-6.7	-27.92	28.49	-2.37	5.96	14.37	-2.77	-2.46	6.69	Upgrade
Free Cash Flow	-24.94	-20.79	-27.79	-25.23	-17.4	-11.69	-9.95	-13.51	-10.36	-4.52	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-	-1704.62%	-	Upgrade
Free Cash Flow Per Share	-1.51	-2.48	-5.23	-6.04	-7.64	-8.36	-16.63	-65.35	-82.39	-266.63	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).